{"id":"W2552984492","doi":"10.1182/blood.v126.23.2861.2861","title":"Panobinostat Plus Azacitidine in Adult Patients with MDS, CMML, or AML: Results of a Phase 2b Study","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Alberta; Princess Margaret Cancer Centre","funders":"","keywords":"Panobinostat; Medicine; Azacitidine; Chronic myelomonocytic leukemia; Internal medicine; Phases of clinical research; International Prognostic Scoring System; Neutropenia; Myelodysplastic syndromes; Bone marrow; Clinical endpoint; Gastroenterology; Oncology; Toxicity; Clinical trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003328236,0.001885078,0.003266198,0.0005107995,0.0005273653,0.00113939,0.0009381853,0.001849738,0.004076159],"category_scores_gemma":[0.00137825,0.0007835735,0.002099027,0.0006361515,0.000967179,0.001259496,0.0004645028,0.003739712,0.001039962],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009878032,"about_ca_system_score_gemma":0.001903263,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001117995,"about_ca_topic_score_gemma":0.002119136,"domain_scores_codex":[0.999007,0.0005492801,0.00006648426,0.0001652424,0.00009329563,0.0001188083],"domain_scores_gemma":[0.9989084,0.0001922626,0.0001800294,0.0001078395,0.00008413688,0.0005272908],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.8260426,0.07823391,0.005233558,0.0008639226,0.002080926,0.0001556451,0.0002083214,0.001133694,0.01981254,0.0001396946,0.002497707,0.06359748],"study_design_scores_gemma":[0.6368017,0.3491872,0.009540125,0.00003831097,0.0007563955,0.0001559809,0.0000338519,0.0003925764,0.001117665,0.0001075785,0.001841873,0.00002686541],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9847963,0.006897527,0.0005752837,0.0008590253,0.0001947748,0.002770474,0.002107525,0.0000904317,0.001708668],"genre_scores_gemma":[0.9699478,0.007872394,0.003664359,0.002645203,0.0007261826,0.005088062,0.006541879,0.00006064188,0.003453587],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004076159,"threshold_uncertainty_score":0.01760161,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03451281276309057,"score_gpt":0.3208866857584335,"score_spread":0.286373872995343,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}